Skip to main content
Recall Canary
Memantine Hydrochloride Extended-Release Capsules
← Back to all recalls
DRUG RECALLMODERATE

Memantine Hydrochloride Extended-Release Capsules

Major Pharmaceuticals is recalling 7 mg Memantine Hydrochloride Extended-Release Capsules due to failed dissolution specifications.

What to do

Contact your healthcare provider or pharmacist if you have concerns about your medication. Do not stop taking your medication without consulting a medical professional.

Recalled
Listed
Updated
Recall No.
D-0485-2026
Agency
FDA
Firm
The Harvard Drug Group LLC
Recall ID
98672
Status
ONGOING

Why it was recalled

Major Pharmaceuticals is recalling Memantine Hydrochloride Extended-Release Capsules, 7 mg, due to failed dissolution specifications. This product was distributed nationwide.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Memantine Hydrochloride Extended-Release, Capsules

Strength
7 mg
NDC / UPC
NDC 0904-6734-61

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other recent recalls from The Harvard Drug Group LLC

All recalls from The Harvard Drug Group LLC

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification